Johnson & Johnson (JNJ) Clears Final Regulatory Hurdle in Synthes Acquisition; Sets Closing Date
Tweet Send to a Friend
Johnson & Johnson (NYSE: JNJ) today announced that it has received U.S. regulatory clearance for its proposed acquisition of Synthes ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
